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The Problem

Giardia intestinalis

 Many Vermonters are familiar with
the term “Beaver Fever” and its
association with illness after
drinking from streams, ponds,
lakes, or other untreated water
sources.

 “Beaver Fever,” or Giardiasis, is
caused by a single-celled parasite
called Giardia intestinalis. Giardia
is found in every state in the
United States and is the most
commonly identified intestinal
parasite in the world.
Giardia intestinalis
https://commons.wikimedia.org/wiki/File:Giardia_intestinalis
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The Problem, cont.
 According to the most recent reports by the CDC, Vermont consistently has
the highest rate of Giardia infection in the nation and has an incidence rate
(number of new infections in the population at a given time) that is
approximately three times higher than that of Maine, the state that ranks
second in Giardia infection.
2012 Incidence Rate of Giardiasis
 Since the risk of infection for Vermonters
is so high, it is important for both patients
and providers to understand the
transmission, symptoms, and treatment of
this very common disease.
 The Health Center, Plainfield, VT, has

identified Giardiasis as a topic of interest
as the providers frequently encounter
patients who have been exposed to Giardia.

https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6403a2.htm
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Public Health Costs
 There are many public health costs associated with Giardia infection that could
be reduced with more patient and provider education
 Cost of annual hospitalizations – Estimated $16-63 million annually
 Cost of medication for treatment of Giardiasis
 Cost of laboratory testing and resources for Giardiasis
 Cost of increased number of physician appointments
 There are many Indirect Costs / Considerations:
 Patients with Giardiasis often have to miss numerous work days
 Younger patients may need to miss school due to illness
 One infected individual can potentially transmit Giardia to numerous
others, thus increasing overall healthcare costs, if not managed
 Since Giardiasis can mimic, or even cause, diseases like irritable bowel
syndrome, peptic ulcer disease, reactive arthritis, and even some types of
cancer, there may be unnecessary healthcare and societal related expenses
3

Community Perspective
 “Many of my patients have non-specific gastrointestinal symptoms and certainly

have giardiasis due to living in Vermont, where it is extremely common” – Melissa
Houser, MD. The Health Center
 “The Health Center providers could benefit from a more definitive protocol to
address empiric treatment of Giardia in varied gastrointestinal presentations.
Research and review of this matter would clarify the widespread use of medications
like Tindamax for symptoms that overlap with IBS, GERD, and other diarrheal
diseases” – Jessica Fisch, PA-C. The Health Center
 “I feel there is a definite need for patient education about Giardia infection.
Anything that will help patients recognize the symptoms of Giardiasis and avoid
initial infection would be invaluable” - Emma Kopecky, NP. The Health Center
 “Because it is transmitted via the fecal-oral route, Giardia can be easily spread not
only through personal contact, but via contaminated water where cysts can survive
for up to three months. This is an especially important mode of transmission in
Vermont where people who enjoy the outdoors may come into contact with water
contaminated by infected wildlife.” – Maeghan O’Neill, PhD. Institute of
Parasitology, McGill University
4

Intervention & Methodology
 Providers at The Health Center identified a
lack of knowledge and informational
resources available to the community about
Giardiasis.
 Created and distributed an

informational brochure that can be used
in waiting rooms or when discussing
Giardiasis with patients (Shown to right)
 Submitted news articles to two
newspapers (The World and The Times
Argus) that are distributed throughout
the Central Vermont community served
by The Health Center
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Intervention & Methodology, cont.
 Providers expressed an interest in
learning more about Giardiasis due
to the large number of patients they
treat for this parasitic infection.
 Provided an oral presentation
and informational handout

about Giardiasis (shown to right)
to physicians, physician
assistants, nurse practitioners,
nurses, and support staff at The
Health Center following a
thorough literature review,
discussion with representatives
at the Institute of Parasitology
(McGill University), CDC, and
Vermont Department of Health
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Results & Response
 Providers and staff at The Health Center responded very positively to the session

focused on provider education regarding Giardiasis in Vermont and to both the
provider and community resources that originated from this project

 Many of the providers indicated that they found the material presented to be “extremely

relevant” to their practice
 Many providers stated the presentation included “information that they otherwise would
not have known”
 One provider stated: “This presentation greatly helped the practice come to consensus
about treatment approach to Giardiasis and was extremely helpful overall!”

 An informational brochure is available to patients in the waiting area of The Health

Center, as well as in electronic format for use by providers when discussing
Giardiasis with patients
 A one page quick-reference handout was provided to all providers to enhance
knowledge related to Giardia, its prevalence in Vermont, symptoms, testing
modalities, and most up-to-date suggestions for treatment
 An educational article was submitted to two local newspapers. At the time of this
project’s conclusion, The Times Argus published the article “Beaver Fever-Giardiasis in Vermont” in the April 22, 2017 edition. The World newspaper
indicated that they would be publishing the informational article about Giardiasis
in the May 3rd, 2017 edition to promote further awareness in the community
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Evaluation of Effectiveness
 Effectiveness
 The goals of this project to promote public and provider awareness about
Giardiasis in Vermont was successfully achieved by providing a handout and
oral presentation to providers, and an educational brochure and newspaper
awareness publication to the patient population
 The primary method for evaluating patient awareness of Giardiasis will be
determined by providers going forward. It can be gauged by the level of
knowledge in the patient population, if the topic comes up, and also by seeing
if patients bring more questions related to Giardia to their provider
 Limitations
 The assessment of effectiveness for educating the community about
Giardiasis will need to be evaluated over time as people have the opportunity
to see the educational resources (brochures and newspaper articles)
 The time constraints of this family medicine rotation do not allow for patient
interviews or surveying to assess the impact of the provided educational
resources
7

Future Directions
 Assess provider perspectives to see if they believe patient awareness of

Giardiasis has been enhanced in the patient population of The Health
Center
 Survey patients for their perspective and perceived knowledge after
educational resources have been available for a given period of time
 Enhanced community outreach could include radio and web-based
information, as well as education at local schools and public events
 Encourage offices and providers to identify patients at risk for exposure to
Giardia, either by age, occupation, or outdoor activity, and discuss
prevention of Giardiasis at office visits
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